Depression Symptom Trajectories Following Child Maltreatment: A Systematic Review of Longitudinal Studies from Adolescence to Young Adulthood.

Trauma Violence AbuseSep 27, 2025 (epub)
Clinical ResearchPsychiatry

Nicola Binks, Kerryann Walsh, Alimila Hayixibayi et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review examined longitudinal changes in depression symptoms after child maltreatment from adolescence to young adulthood. Searches identified 87 eligible studies, but only 13 assessed symptom change over time. Results were mixed: most of these studies found severe or worsening symptom trajectories, while some identified improvement in subgroups. Across studies, depression symptoms generally remained worse than among people without maltreatment histories. Findings on factors shaping symptom change were inconsistent, although school-related factors showed a consistent influence in the smaller subset examining environmental factors.

Key findings

  • Of 87 eligible studies, only 13 examined changes in depression symptoms over time.
  • Most studies assessing symptom change found severe or worsening trajectories; some reported improvement in subgroups.
  • Across studies, depression symptoms remained relatively worse than in individuals without child maltreatment histories.
  • Findings on influencing factors were inconsistent, while school-related environmental factors consistently affected the relationship.

Why it matters

The review indicates that depression after childhood maltreatment may follow varied courses, but symptoms often remain elevated relative to those in people without such histories. Recognising this heterogeneity can inform ongoing assessment during adolescence and young adulthood, while the limited and inconsistent evidence on modifying factors cautions against assuming a uniform trajectory.

What to keep in mind

Only 13 of the 87 included studies examined symptom change, and findings were mixed; evidence on factors influencing trajectories was also inconsistent.

Source

Published in Trauma Violence Abuse. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.